GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » Change In Receivables

Hans Biomed (XKRX:042520) Change In Receivables : ₩-5,055 Mil (TTM As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed Change In Receivables?

Hans Biomed's change in receivables for the quarter that ended in Mar. 2025 was ₩-4,484 Mil. It means Hans Biomed's Accounts Receivable increased by ₩4,484 Mil from Dec. 2024 to Mar. 2025 .

Hans Biomed's change in receivables for the fiscal year that ended in Sep. 2024 was ₩-2,079 Mil. It means Hans Biomed's Accounts Receivable increased by ₩2,079 Mil from Sep. 2023 to Sep. 2024 .

Hans Biomed's Accounts Receivable for the quarter that ended in Mar. 2025 was ₩14,249 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hans Biomed's Days Sales Outstanding for the three months ended in Mar. 2025 was 53.83.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hans Biomed's liquidation value for the three months ended in Mar. 2025 was ₩-26,805 Mil.


Hans Biomed Change In Receivables Historical Data

The historical data trend for Hans Biomed's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed Change In Receivables Chart

Hans Biomed Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,857.89 1,039.19 1,207.76 -3,943.93 -2,078.99

Hans Biomed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 789.95 -30.79 -1,299.51 758.77 -4,483.95

Hans Biomed Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-5,055 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hans Biomed  (XKRX:042520) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hans Biomed's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=14249.347/24155.166*91
=53.83

2. In Ben Graham's calculation of liquidation value, Hans Biomed's accounts receivable are only considered to be worth 75% of book value:

Hans Biomed's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=11747.109-63384.455+0.75 * 14249.347+0.5 * 28291.537
=-26,805

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hans Biomed Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hans Biomed's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Hans Biomed Business Description

Traded in Other Exchanges
N/A
Address
No.7, Jeong-i-ro 8-gil, Songpa-gu, Seoul, KOR
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures and sells skin and bone grafts for human transplantation, medical devices, silicone products, etc.

Hans Biomed Headlines

No Headlines